| Financial Year |
March 31 2023 |
| Monetary Funds |
1,784,801,672.93 |
| Held-for-trading Financial Assets |
472,017,580.00 |
| Notes Receivable |
950,000.00 |
| Accounts Receivable |
407,676,818.73 |
| Advances to Suppliers |
90,271,596.32 |
| Other Receivables |
23,751,258.79 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
670,888,492.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,757,594.09 |
| Total Current Assets |
3,711,406,291.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
220,694,997.13 |
| Investment Properties |
140,645,083.36 |
| Fixed Assetes |
619,267,999.67 |
| Under-construction Projects |
122,773,397.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
153,731,807.74 |
| R&D expenses |
-- |
| Goodwill |
3,332,639.48 |
| Long-Term Deferred and Prepaid Expenses |
1,381,325.71 |
| Deferred Income Tax Assets |
28,900,954.98 |
| Other Non-Current Assets |
12,301,447.61 |
| Sub-Total of Non-Current Assets |
1,307,413,303.99 |
| Total Assets |
5,018,819,595.22 |
| Short-Term Loans |
641,322,197.68 |
| Trading Financial liabilities |
5,592,334.00 |
| Notes Payable |
189,979,359.54 |
| Accounts Payable |
372,226,661.91 |
| Accounts Received In Advance |
5,743,756.74 |
| Employee Compensation Payable |
47,477,845.55 |
| Taxes Payable |
20,019,700.20 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
91,643,683.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,577,393.02 |
| Other Current Liabilities |
24,574,116.09 |
| Sub-Total of Current Liabilities |
1,615,394,975.42 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,275,705.87 |
| Deferred Income Tax Liabilities |
21,757,402.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
60,697,150.37 |
| Total Liabilities |
1,676,092,125.79 |
| Paid-In Capital(Or Share Stock) |
445,515,368.00 |
| Capital Surplus |
1,498,979,970.49 |
| Surplus Reserve |
184,958,125.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,184,334,623.17 |
| Minority Stockholder's Interest |
35,239,213.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,307,488,255.61 |
| Owner's Equity（Stockholder's Equity） |
3,342,727,469.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,018,819,595.22 |
